Latest Progressive bulbar palsy Stories
An investigational treatment for an inherited form of Lou Gehrig’s disease has passed an early phase clinical trial for safety.
For decades, scientists have studied a laboratory mouse model that develops signs of the paralyzing disease amyotrophic lateral sclerosis (ALS) as they age.
Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis (ALS).
New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder.
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice.
A U.S.-led team of scientists says it has discovered a new gene mutation, ALS6, that might lead to new treatments for amyotrophic lateral sclerosis. ALS, also known as Lou Gehrig's disease, is a progressive, neurodegenerative disease that affects nerve cells in the brain and spinal cord. The researchers said their discovery provides important clues to the causes of inherited ALS, which accounts for 10 percent of all cases, and sporadic ALS, which accounts for the other 90 percent and occurs...